Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
PHASE4
INTERVENTIONAL
2018-04-01
2018-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Commercial Single Step (Vitrolife -G-TLâ„¢) Media Compared With Cornell Media
NCT02527642
Comparison of Human Embryo Development Using Sequential and Single Media With Time-lapse Imaging
NCT01939626
Comparison Of The Embryoscope Time-Lapse System With Standard Embryo Culture
NCT02246309
Randomized Trial Comparing EmbryoScope With EmbryoScope+.
NCT03522350
Single-step Versus Sequential Media in Preimplantation Embryo Development and Pregnancy Rates
NCT02048527
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Global is a FDA approved commercial single-step medium for all embryo culture from Day 0 to the blastocyst stage.
G-TL (Time-Lapse) is a FDA approved commercial single-step medium from Vitrolife. It was developed to be used with time-lapse devices as a continuous embryo culture medium from Day 0 to Day 5/6.
C3 is Cornell's in house made single-step buffered medium for embryo culture from oocyte fertilization to blastocyst stage used as standard of care.
C1/C2 is Cornell's in house made buffered sequential medium otherwise known as multi step medium, use to culture embryos for development. It is formulated to meet the embryos requirements at two specific stages of development but require removal of the dish from the incubator to physically exchange the culture media surrounding the embryos. This medium will be the control.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Global vs. G-TL Media
Global medium will be compared with G-TL (Time-Lapse) medium.
Global vs. G-TL vs Cornell's C3 vs Cornell's C1/C2 media
A comparison between Global, G-TL, Cornell's C3, and Cornell's C1/C2 embryo culture media.
Global vs. Cornell's C3 Media
Global medium will be compared with Cornell's C3 single step medium.
Global vs. G-TL vs Cornell's C3 vs Cornell's C1/C2 media
A comparison between Global, G-TL, Cornell's C3, and Cornell's C1/C2 embryo culture media.
Global vs. Cornell's sequential Media
Global medium will be compared with Cornell's C1/C2 sequential medium.
Global vs. G-TL vs Cornell's C3 vs Cornell's C1/C2 media
A comparison between Global, G-TL, Cornell's C3, and Cornell's C1/C2 embryo culture media.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Global vs. G-TL vs Cornell's C3 vs Cornell's C1/C2 media
A comparison between Global, G-TL, Cornell's C3, and Cornell's C1/C2 embryo culture media.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 65 years of age or younger (paternal)
* 10 or more oocytes
* Fresh or frozen oocytes (including donor)
* Fresh or frozen (including donor) sperm can be used
* ICSI only
* Frozen embryos from this study can be included in the outcome portion of this study.
* PGD and/or PGS patients included
Exclusion Criteria
* Co-culture patients
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Weill Medical College of Cornell University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nikica Zaninovic, PhD
Role: PRINCIPAL_INVESTIGATOR
Weill Medical College of Cornell University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Center for Reproductive Medicine
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1707018347
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.